TN to launch trial to study efficacy of BCG vaccine to reduce COVID-19 mortality for elders
This is significant as the study will see whether the vaccine ’s potential to combat Covid-19 and prevent hospitalisation among the aged as they are more susceptible to picking up the infection as they often suffer from co-morbid conditions.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | COVID-19 | Pharmaceuticals | Study | Tuberculosis (BCG) Vaccine | Vaccines